Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.

Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis.

Eating behavior in continuous ambulatory peritoneal dialysis and hemodialysis patients.

Renal osteodystrophy in patients on continuous ambulatory peritoneal dialysis.

Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis.

Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.

Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis.

Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.

Effect of exercise program on lumbosacral strain in patients on continuous ambulatory peritoneal dialysis.

Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis.

Multicenter study of change in dialysis therapy-maintenance hemodialysis to continuous ambulatory peritoneal dialysis.

Abdominal Obesity and Mortality in Continuous Ambulatory Peritoneal Dialysis Patients.

Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.

Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.

Continuous ambulatory peritoneal dialysis in Canada.

Detective work in continuous ambulatory peritoneal dialysis.

Continuous ambulatory peritoneal dialysis associated with peritonitis in older patients.

Potassium metabolism in continuous ambulatory peritoneal dialysis patients.

Factors associated with Hypokalemia in Continuous Ambulatory Peritoneal Dialysis Patients.

Blood pressure profile in continuous ambulatory peritoneal dialysis patients.

Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis.

Encephalopathy in patients on continuous ambulatory peritoneal dialysis and patients on chronic haemodialysis.

Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis.

Factors influencing peritoneal catheter survival in continuous ambulatory peritoneal dialysis.

Sleep disorders in patients with end-stage renal disease undergoing dialysis: comparison between hemodialysis, continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.

Suggest Documents

Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis.

Eating behavior in continuous ambulatory peritoneal dialysis and hemodialysis patients.

Renal osteodystrophy in patients on continuous ambulatory peritoneal dialysis.

Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis.

Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis.

Pharmacokinetics and dose response after intravenous and subcutaneous administration of recombinant erythropoietin in patients on regular haemodialysis treatment or continuous ambulatory peritoneal dialysis.

Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.

Effect of exercise program on lumbosacral strain in patients on continuous ambulatory peritoneal dialysis.

Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis.

Multicenter study of change in dialysis therapy-maintenance hemodialysis to continuous ambulatory peritoneal dialysis.

Abdominal Obesity and Mortality in Continuous Ambulatory Peritoneal Dialysis Patients.

Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.

Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.

Continuous ambulatory peritoneal dialysis in Canada.

Detective work in continuous ambulatory peritoneal dialysis.

Continuous ambulatory peritoneal dialysis associated with peritonitis in older patients.

Potassium metabolism in continuous ambulatory peritoneal dialysis patients.

Factors associated with Hypokalemia in Continuous Ambulatory Peritoneal Dialysis Patients.

Blood pressure profile in continuous ambulatory peritoneal dialysis patients.

Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis.

Encephalopathy in patients on continuous ambulatory peritoneal dialysis and patients on chronic haemodialysis.

Peritoneal morphology in children treated by continuous ambulatory peritoneal dialysis.

Factors influencing peritoneal catheter survival in continuous ambulatory peritoneal dialysis.

Sleep disorders in patients with end-stage renal disease undergoing dialysis: comparison between hemodialysis, continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.

Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients.

Recommend Documents

Follow Us